EMERGENCE OF DRUG-RESISTANCE IN TUMORS - CHARACTERISTIC WHICH MAY BE EXPLOITED THERAPEUTICALLY

被引：5

作者：

TATTERSALL, MH

机构：

[1] ROY POSTGRAD MED SCH, DEPT HAEMATOL, LONDON W12, ENGLAND

[2] ROY POSTGRAD MED SCH, MRC, LEUKAEMIA UNIT, LONDON W12, ENGLAND

来源：

BRITISH JOURNAL OF CANCER | 1973年 / 27卷 / 05期

关键词：

D O I：

10.1038/bjc.1973.49

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：406 / 408

页数：3

共 12 条

[1]

BRUCE WR, 1966, JNCI-J NATL CANCER I, V37, P233

[2]

CAPIZZI RL, 1970, CANCER RES, V30, P1782

[3]

DJERASSI I, 1972, CANCER, V30, P22, DOI 10.1002/1097-0142(197207)30:1<22::AID-CNCR2820300105>3.0.CO

[4]

2-B

[5] 5-FLUOROCYTOSINE IN TREATMENT OF CRYPTOCOCCAL AND CANDIDA MYCOSES [J].

FASS, RJ ;

PERKINS, RL .

ANNALS OF INTERNAL MEDICINE, 1971, 74 (04) :535-+

[6]

FRIEDKIN M, 1962, CANCER RES, V22, P600

[7] TETRAHYDROHOMOFOLATE SPECIFIC INHIBITOR OF THYMIDYLATE SYNTHETASE [J].

GOODMAN, L ;

KISLIUK, RL ;

FRIEDKIN, M ;

MORNINGSTAR, JF ;

KWOK, G ;

PASTORE, EJ ;

RATZAN, J ;

CRAWFORD, EJ ;

ALNAHAS, A ;

DONOVAN, EF ;

WILSON, L ;

PLANTE, LT ;

DEGRAW, J .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1964, 86 (02) :308-&

[8] FLUORINATED PYRIMIDINES, A NEW CLASS OF TUMOUR-INHIBITORY COMPOUNDS [J].

HEIDELBERGER, C ;

CHAUDHURI, NK ;

DANNEBERG, P ;

MOOREN, D ;

GRIESBACH, L ;

DUSCHINSKY, R ;

SCHNITZER, RJ ;

PLEVEN, E ;

SCHEINER, J .

NATURE, 1957, 179 (4561) :663-666

[9] METABOLISM OF 5-FLUOROCYTOSINE-214C AND OF CYTOSINE-14C IN RAT AND DISPOSITION OF 5-FLUOROCYTOSINE-214C IN MAN [J].

KOECHLIN, BA ;

RUBIO, F ;

PALMER, S ;

GABRIEL, T ;

DUSCHINSKY, R .

BIOCHEMICAL PHARMACOLOGY, 1966, 15 (04) :435-+

[10] FURTHER EVALUATION OF ANTITUMOR ACTIVITY OF HOMOFOLATE AND ITS REDUCED DERIVATIVES AGAINST METHOTREXATE-INSENSITIVE TUMORS [J].

MISHRA, LC ;

MEAD, JAR .

CHEMOTHERAPY, 1972, 17 (04) :283-&

← 1 2 →